See more : Navin Fluorine International Limited (NAVINFLUOR.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beihai Gofar Chuanshan Biological Co., Ltd., a leading company in the Agricultural Inputs industry within the Basic Materials sector.
You may be interested
- Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) Income Statement Analysis – Financial Results
- Nippon Information Development Co., Ltd. (2349.T) Income Statement Analysis – Financial Results
- Mawson Gold Limited (MWSNF) Income Statement Analysis – Financial Results
- Supremex Inc. (SXP.TO) Income Statement Analysis – Financial Results
- PT Bhakti Agung Propertindo Tbk (BAPI.JK) Income Statement Analysis – Financial Results
Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS)
About Beihai Gofar Chuanshan Biological Co., Ltd.
Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eyesight eye drops, gastrointestinal granules, pearl powder, and other proprietary Chinese medicines. It also provides molecular medical imaging and tumor radiotherapy centers, as well as tumor telemedicine technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in May 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was founded in 1993 is based in Beihai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 369.15M | 459.68M | 424.72M | 267.70M | 251.15M | 224.52M | 434.49M | 455.41M | 506.41M | 415.41M | 452.42M | 542.98M | 528.70M | 363.30M | 241.32M | 325.97M | 789.65M | 539.19M | 462.00M | 373.38M | 231.16M | 99.01M | 94.06M | 81.44M | 64.18M |
| Cost of Revenue | 279.46M | 331.47M | 315.18M | 200.63M | 204.20M | 180.14M | 355.22M | 406.19M | 422.21M | 369.88M | 382.19M | 461.19M | 455.53M | 317.23M | 210.55M | 295.33M | 611.02M | 419.13M | 328.72M | 256.53M | 128.19M | 38.10M | 34.48M | 28.97M | 20.54M |
| Gross Profit | 89.70M | 128.21M | 109.54M | 67.07M | 46.95M | 44.38M | 79.26M | 49.21M | 84.20M | 45.53M | 70.22M | 81.79M | 73.17M | 46.07M | 30.77M | 30.64M | 178.64M | 120.06M | 133.28M | 116.85M | 102.97M | 60.91M | 59.58M | 52.47M | 43.64M |
| Gross Profit Ratio | 24.30% | 27.89% | 25.79% | 25.05% | 18.69% | 19.77% | 18.24% | 10.81% | 16.63% | 10.96% | 15.52% | 15.06% | 13.84% | 12.68% | 12.75% | 9.40% | 22.62% | 22.27% | 28.85% | 31.30% | 44.55% | 61.52% | 63.34% | 64.43% | 68.00% |
| Research & Development | 11.71M | 8.38M | 9.14M | 50.13K | 75.57K | 250.32K | 949.17K | 1.91M | 1.07M | 1.11M | 4.10M | 3.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 23.99M | 17.09M | 16.97M | 12.49M | 9.90M | 11.09M | 16.77M | 25.44M | 16.26M | 24.02M | 17.49M | 18.86M | 16.13M | 18.49M | 41.61M | 38.51M | 45.96M | 56.40M | 48.90M | 37.40M | 37.67M | 13.43M | 13.22M | 13.28M | 11.67M |
| Selling & Marketing | 14.91M | 34.87M | 38.53M | 30.04M | 28.51M | 34.64M | 35.40M | 38.22M | 32.20M | 34.06M | 35.53M | 47.28M | 39.97M | 29.48M | 27.32M | 25.47M | 72.87M | 42.14M | 33.05M | 36.37M | 26.23M | 18.06M | 14.47M | 9.50M | 6.46M |
| SG&A | 56.96M | 51.97M | 55.49M | 42.52M | 38.40M | 45.73M | 52.16M | 63.65M | 48.46M | 58.07M | 53.01M | 66.14M | 56.10M | 47.97M | 68.93M | 63.98M | 118.83M | 98.54M | 81.96M | 73.78M | 63.91M | 31.49M | 27.70M | 22.77M | 18.12M |
| Other Expenses | 98.79M | 35.40M | 28.73M | 19.30M | 18.52M | -460.10K | -546.62K | 1.84M | 2.70M | 2.04M | 36.76M | 599.56K | 5.45M | 80.04M | 6.54M | -7.98M | 6.59M | 8.89M | 10.69M | 5.85M | 547.47K | 130.70K | 2.93M | -155.35K | -233.56K |
| Operating Expenses | 167.46M | 95.74M | 93.37M | 61.87M | 57.00M | 70.48M | 90.00M | 97.45M | 79.93M | 88.49M | 79.90M | 102.34M | 87.46M | 87.06M | 72.98M | 69.75M | 124.96M | 99.92M | 83.82M | 75.90M | 65.92M | 33.98M | 30.56M | 25.75M | 21.19M |
| Cost & Expenses | 446.92M | 427.21M | 408.55M | 262.51M | 261.20M | 250.62M | 445.23M | 503.64M | 502.14M | 458.38M | 462.09M | 563.53M | 542.99M | 404.30M | 283.53M | 365.07M | 735.98M | 519.05M | 412.54M | 332.42M | 194.11M | 72.08M | 65.04M | 54.72M | 41.73M |
| Interest Income | 3.58M | 4.71M | 4.00M | 7.50M | 7.65M | 4.36M | 1.18M | 620.43K | 2.12M | 4.82M | 108.69K | 206.52K | 64.33K | 1.41M | 0.00 | -0.07 | -0.79 | 3.03M | 2.90M | 2.99M | 2.81M | 362.05K | 244.83K | 137.73K | -0.40 |
| Interest Expense | 451.59K | 505.05K | 527.75K | 113.74K | 98.22K | 87.02K | 6.54M | 3.71M | 3.78M | 11.66M | 6.55M | 12.15M | 9.62M | 37.66M | 78.67M | 65.98M | 42.78M | 41.85M | 34.36M | 25.11M | 7.57M | 3.23M | 3.38M | 2.87M | 2.49M |
| Depreciation & Amortization | 14.26M | 14.29M | 13.76M | 12.69M | 16.58M | 14.43M | 28.53M | 27.01M | 25.25M | 24.11M | 22.17M | 26.55M | 25.50M | 37.23M | 37.91M | 38.79M | 39.61M | 27.96M | 25.73M | 12.71M | 6.71M | 5.45M | 4.98M | 2.72M | 2.49M |
| EBITDA | -52.96M | 58.69M | 31.36M | 24.29M | 28.63M | -5.23M | 39.52M | -11.28M | 40.00M | -26.12M | 42.51M | -62.29M | 2.49M | 92.12M | -28.24M | 8.44M | 92.71M | 58.85M | 88.05M | 61.42M | 46.96M | 32.77M | 33.98M | 26.71M | 22.45M |
| EBITDA Ratio | -14.35% | 14.16% | 8.53% | 8.55% | 6.62% | -1.71% | 9.47% | -2.48% | 8.79% | -2.85% | 10.51% | 1.25% | 2.68% | 27.65% | 18.63% | 21.61% | 12.21% | 10.91% | 19.06% | 16.45% | 20.32% | 33.10% | 36.12% | 32.79% | 34.98% |
| Operating Income | -77.76M | 42.28M | 20.47M | 8.82M | 1.21M | -20.70M | 4.38M | -50.21M | 6.99M | -57.28M | -22.88M | -85.06M | -38.01M | -62.71M | -145.10M | -167.60M | 24.61M | -16.17M | 23.83M | 25.06M | 32.35M | 23.96M | 25.85M | 23.99M | 19.96M |
| Operating Income Ratio | -21.07% | 9.20% | 4.82% | 3.30% | 0.48% | -9.22% | 1.01% | -11.03% | 1.38% | -13.79% | -5.06% | -15.67% | -7.19% | -17.26% | -60.13% | -51.42% | 3.12% | -3.00% | 5.16% | 6.71% | 14.00% | 24.20% | 27.49% | 29.45% | 31.10% |
| Total Other Income/Expenses | 197.61K | -174.36K | 630.08K | 748.90K | 844.09K | -460.10K | -546.62K | 1.69M | 2.63M | -7.31M | 36.50M | -45.11M | -5.70M | 79.94M | -82.66M | -141.24M | -21.64M | -40.70M | -28.08M | -24.67M | 317.76K | 125.49K | -235.82K | -152.60K | -232.75K |
| Income Before Tax | -77.57M | 42.11M | 15.79M | 9.57M | 10.41M | -21.16M | 3.84M | -48.52M | 9.61M | -64.59M | 13.63M | -101.14M | -32.66M | 17.23M | -141.52M | -176.64M | 31.46M | -10.96M | 27.95M | 23.59M | 32.67M | 24.08M | 25.62M | 23.84M | 19.73M |
| Income Before Tax Ratio | -21.01% | 9.16% | 3.72% | 3.58% | 4.15% | -9.43% | 0.88% | -10.65% | 1.90% | -15.55% | 3.01% | -18.63% | -6.18% | 4.74% | -58.64% | -54.19% | 3.98% | -2.03% | 6.05% | 6.32% | 14.13% | 24.32% | 27.23% | 29.27% | 30.74% |
| Income Tax Expense | 3.59M | 5.45M | 5.86M | 6.37M | 4.64M | 446.81K | 1.48M | 528.36K | 1.36M | 205.98K | 2.28M | 3.28M | 1.16M | 158.67K | -912.45K | 1.70M | 12.84M | 8.16M | 2.72M | 2.33M | 2.38M | 519.47K | 827.29K | 8.17M | 3.52M |
| Net Income | -82.31M | 34.84M | 10.49M | 3.20M | 5.77M | -21.61M | 8.85M | -31.86M | 4.05M | -49.20M | 10.69M | -109.57M | -39.04M | 16.40M | -138.43M | -176.71M | 3.04M | -30.22M | 17.74M | 16.21M | 28.09M | 23.69M | 24.59M | 15.61M | 16.22M |
| Net Income Ratio | -22.30% | 7.58% | 2.47% | 1.20% | 2.30% | -9.63% | 2.04% | -7.00% | 0.80% | -11.84% | 2.36% | -20.18% | -7.38% | 4.52% | -57.36% | -54.21% | 0.38% | -5.60% | 3.84% | 4.34% | 12.15% | 23.93% | 26.15% | 19.16% | 25.27% |
| EPS | -0.16 | 0.07 | 0.02 | 0.01 | 0.01 | -0.05 | 0.02 | -0.07 | 0.01 | -0.13 | 0.04 | -0.39 | -0.14 | 0.06 | -0.50 | -0.63 | 0.01 | -0.11 | 0.06 | 0.06 | 0.10 | 0.14 | 0.09 | 0.06 | 0.06 |
| EPS Diluted | -0.16 | 0.07 | 0.02 | 0.01 | 0.01 | -0.05 | 0.02 | -0.07 | 0.01 | -0.13 | 0.04 | -0.39 | -0.14 | 0.06 | -0.50 | -0.63 | 0.01 | -0.11 | 0.06 | 0.06 | 0.10 | 0.14 | 0.09 | 0.06 | 0.06 |
| Weighted Avg Shares Out | 514.43M | 524.20M | 524.20M | 511.77M | 464.40M | 432.22M | 442.53M | 455.17M | 405.31M | 378.43M | 267.21M | 280.94M | 278.87M | 273.39M | 276.86M | 279.35M | 258.49M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M |
| Weighted Avg Shares Out (Dil) | 514.43M | 524.20M | 524.20M | 511.77M | 464.40M | 432.22M | 442.53M | 455.17M | 405.31M | 378.43M | 267.21M | 280.94M | 278.87M | 273.39M | 276.86M | 279.35M | 258.49M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M | 271.69M |
No news found for: 600538.SS
Source: https://incomestatements.info
Category: Stock Reports